chr17-49133126-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000300404.2(B4GALNT2):āc.101G>Cā(p.Gly34Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000843 in 1,530,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000300404.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
B4GALNT2 | NM_001159387.2 | c.14+320G>C | intron_variant | ENST00000393354.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
B4GALNT2 | ENST00000300404.2 | c.101G>C | p.Gly34Ala | missense_variant | 1/11 | 1 | |||
B4GALNT2 | ENST00000393354.7 | c.14+320G>C | intron_variant | 1 | NM_001159387.2 | P1 | |||
B4GALNT2 | ENST00000504681.5 | c.-65+616G>C | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152166Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000153 AC: 25AN: 163632Hom.: 0 AF XY: 0.000120 AC XY: 11AN XY: 91792
GnomAD4 exome AF: 0.0000885 AC: 122AN: 1378634Hom.: 0 Cov.: 69 AF XY: 0.0000774 AC XY: 53AN XY: 684610
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152166Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2022 | The c.101G>C (p.G34A) alteration is located in exon 1 (coding exon 1) of the B4GALNT2 gene. This alteration results from a G to C substitution at nucleotide position 101, causing the glycine (G) at amino acid position 34 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at